Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babs G Taal

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuroendocrinology|October 9, 2008
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine TumorsCatharina M Korse, Johannes M G Bonfrer, Neil K Aaronson, et al.
World Journal of Surgical Oncology|November 19, 2005
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablationVincent Meij, Johanna M Zuetenhorst, Richard van Hillegersberg, et al.
Cancer|March 26, 2003
Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factorJohanna M Zuetenhorst, Johannes M G M Bonfrer, Catharina M Korse, et al.
Clinical Chemistry|July 13, 2004
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumorsJohanna M Zuetenhorst, Catharina M Korse, Johannes M G Bonfrer, et al.
Gastrointestinal Endoscopy|July 4, 2006
Detection of small-bowel neuroendocrine tumors by video capsule endoscopySebastiaan A C van Tuyl, Jacco Tenthof van Noorden, Robin Timmer, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counsellingEveline M A Bleiker, Fred H Menko, Irma Kluijt, et al.
Diseases of the Colon and Rectum|December 11, 2002
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 familiesWouter H de Vos tot Nederveen Cappel, Fokko M Nagengast, Gerrit Griffioen, et al.
Human Pathology|November 28, 2002
Classification of low-grade neuroendocrine tumors of midgut and unknown originSusanne Van Eeden, Pascal F H J Quaedvlieg, Babs G Taal, et al.
Gastroenterology|February 3, 2005
Screening behavior of individuals at high risk for colorectal cancerEveline M A Bleiker, Fred H Menko, Babs G Taal, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragmentsCatharina M Korse, Babs G Taal, Andrew Vincent, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuroendocrinology|October 9, 2008
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine TumorsCatharina M Korse, Johannes M G Bonfrer, Neil K Aaronson, et al.
World Journal of Surgical Oncology|November 19, 2005
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablationVincent Meij, Johanna M Zuetenhorst, Richard van Hillegersberg, et al.
Cancer|March 26, 2003
Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factorJohanna M Zuetenhorst, Johannes M G M Bonfrer, Catharina M Korse, et al.
Clinical Chemistry|July 13, 2004
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumorsJohanna M Zuetenhorst, Catharina M Korse, Johannes M G Bonfrer, et al.
Gastrointestinal Endoscopy|July 4, 2006
Detection of small-bowel neuroendocrine tumors by video capsule endoscopySebastiaan A C van Tuyl, Jacco Tenthof van Noorden, Robin Timmer, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counsellingEveline M A Bleiker, Fred H Menko, Irma Kluijt, et al.
Diseases of the Colon and Rectum|December 11, 2002
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 familiesWouter H de Vos tot Nederveen Cappel, Fokko M Nagengast, Gerrit Griffioen, et al.
Human Pathology|November 28, 2002
Classification of low-grade neuroendocrine tumors of midgut and unknown originSusanne Van Eeden, Pascal F H J Quaedvlieg, Babs G Taal, et al.
Gastroenterology|February 3, 2005
Screening behavior of individuals at high risk for colorectal cancerEveline M A Bleiker, Fred H Menko, Babs G Taal, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragmentsCatharina M Korse, Babs G Taal, Andrew Vincent, et al.
Pageof 3